Literature DB >> 6893266

Amphotericin B-induced myelopathy.

N T Carnevale, J N Galgiani, D A Stevens, M K Herrick, J W Langston.   

Abstract

Two patients with coccidioidal meningitis experienced transient neurologic deficits shortly after receiving intrathecal injections of amphotericin B. Continuation of treatment eventually led to a severe flaccid paraparesis with a thoracic sensory level in one patient, and a partial Brown-Séquard's syndrome in the other. Myelography was normal in both, with no evidence of arachnoiditis. Autopsy findings in the first patient showed a focal area of necrosis in the left half of the spinal cord consistent with the patient's clinical findings during life. The distribution of the lesion corresponded to the area supplied by a central sulcal artery. Amphotericin B may exert a direct toxic effect on the spinal cord or its vascular supply when given intrathecally.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6893266

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  8 in total

1.  Comparative toxicities and pharmacokinetics of intrathecal lipid (amphotericin B colloidal dispersion) and conventional deoxycholate formulations of amphotericin B in rabbits.

Authors:  K V Clemons; R A Sobel; P L Williams; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

3.  Comparative toxicities of amphotericin B and its monomethyl ester derivative on glial cells in culture.

Authors:  S P Racis; O J Plescia; H M Geller; C P Schaffner
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

4.  Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management.

Authors:  P E Verweij; K Brinkman; H P Kremer; B J Kullberg; J F Meis
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

Review 5.  Antifungal agents used in systemic mycoses. Activity and therapeutic use.

Authors:  J R Graybill; P C Craven
Journal:  Drugs       Date:  1983-01       Impact factor: 9.546

6.  Amphotericin B in the treatment of coccidioidomycosis.

Authors:  D J Drutz
Journal:  Drugs       Date:  1983-10       Impact factor: 9.546

7.  Comparative neurotoxicities of amphotericin B and its mono-methyl ester derivative in rats.

Authors:  K R Reuhl; M Vapiwala; M T Ryzlak; C P Schaffner
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

Review 8.  Miconazole in the treatment of coccidioidomycosis.

Authors:  D A Stevens
Journal:  Drugs       Date:  1983-10       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.